Originally published In Press as doi:10.1074/jbc.M106846200 on December 10, 2001
J. Biol. Chem., Vol. 277, Issue 7, 5385-5394, February 15, 2002
Cooperation of Yeast Peroxiredoxins Tsa1p and Tsa2p in the
Cellular Defense against Oxidative and Nitrosative Stress*
Chi-Ming
Wong,
Yuan
Zhou,
Raymond W. M.
Ng,
Hsiang-fu
Kung, and
Dong-Yan
Jin
From the Institute of Molecular Biology, The University of Hong
Kong, Pokfulam Rd., Hong Kong, China
Received for publication, July 19, 2001, and in revised form, November 13, 2001
 |
ABSTRACT |
Peroxiredoxins are a family of antioxidant
enzymes conserved from bacteria to humans. In Saccharomyces
cerevisiae, there exist five peroxiredoxins, among which Tsa2p
shares striking homology with the well described Tsa1p but has not been
extensively studied. Here we report on the functional characterization
of yeast tsa2
mutants and the comparison of
TSA1 with TSA2. The tsa2
and
tsa1
tsa2
cells grew normally under
aerobic conditions. However, the tsa1
tsa2
mutant yeast was more susceptible to oxidants than either tsa1
or tsa2
cells. Notably, the
tsa1
tsa2
yeast was also hypersensitive
to peroxynitrite and sodium nitroprusside. This phenotype was rescued
by the expression of either the TSA1 or TSA2
gene. The demonstration of a peroxynitrite reductase activity of Tsa2p
in vitro points to a pivotal role for peroxiredoxins in the
protection against nitrosative stress. In yeast cells, Tsa1p and Tsa2p
exhibited comparable antioxidant activity. While the basal expression
level of TSA1 was significantly higher than that of
TSA2, the transcription of TSA2 was stimulated
more potently by various oxidants. In addition, TSA2 was
activated in tsa1
cells in a Yap1p-dependent
manner. Taken together, our findings implicate the cooperation of Tsa1p
and Tsa2p in the cellular defense against reactive oxygen and nitrogen species.
 |
INTRODUCTION |
Living organisms are constantly exposed to reactive oxygen species
(ROS)1 that are produced
during metabolism or in response to external stimuli (1). In addition
to ROS, reactive nitrogen species (RNS) have emerged as another source
of oxidative and nitrosative stress (2, 3). Both ROS and RNS have been
implicated in various physiological and pathological processes
including metabolism, immunity, inflammation, cell signaling,
transcriptional regulation, and apoptosis (1-3). The cellular defense
against oxidative and nitrosative stress is important for homeostasis
and survival.
Antioxidant enzymes are important components of the cellular defense
system against ROS and RNS. In addition to well documented antioxidant
enzymes such as superoxide dismutase and catalase, a novel family of
peroxidases, designated peroxiredoxins, has recently been characterized
(4-6). Peroxiredoxins are found in all organisms ranging from bacteria
to humans. They are thought to be active peroxidases supported by
thioredoxin and other electron donors (5, 7). The amino acid sequences
around the peroxidatic center characterized by a cysteine residue are
highly conserved. The oxidation of the cysteine induced the formation
of a decameric structure comprising five dimers (8, 9). In a more
recent study, bacterial peroxiredoxin AhpC has been shown to be
peroxynitrite reductase (10), thus conferring resistance to RNS (11).
It remains to be seen whether eukaryotic peroxiredoxins can generally scavenge peroxynitrite in addition to hydrogen peroxide and directly protect cells from RNS.
Multiple subtypes of peroxiredoxins are often found in one species (6).
Thus, there are five peroxiredoxin genes (TSA1/cTPxI/YML026W, TSA2/cTPxII/YDR453C, BCP/nTPx/DOT5/YIL010W, 1CPrx/mTPx/YBL064C, and
PMP20/AHP1/cTPxIII/YLR109W) in Saccharomyces cerevisiae (5, 12-16). Tsa1p is the first identified peroxiredoxin, and it has been
shown to be the major thioredoxin peroxidase in the cytoplasm (5, 16).
1CPrx localizes to mitochondria (15), and PMP20 resides in peroxisomes
(12-14). Different peroxiredoxins in yeast are thought to have
redundant and nonredundant functions (16). Notably, four of the five
yeast peroxiredoxins have mammalian orthologs (4, 5, 17-28). Thus, the
budding yeast represents an attractive model for the study of peroxiredoxins.
To date, only a limited number of enzymes in the large family of
peroxiredoxins have been characterized for function. Fundamental questions as to whether and how peroxiredoxins scavenge RNS and ROS
remain unanswered. Coordinated efforts using different biological systems are necessary for functional studies. One route toward understanding the physiology of peroxiredoxins is through the phenotype
of null mutants in yeasts. Among the yeast peroxiredoxins, Tsa2p is
highly homologous to the well described Tsa1p (5, 7). However, Tsa2p
has been shown to be very different from Tsa1p and other peroxiredoxins
in yeast. Surprisingly, TSA2-null mutants suffered a severe
growth retardation characterized by the accumulation of G1
cells and were insensitive to oxidants (16). To shed additional light
on the physiological functions of Tsa2p, we constructed and
characterized tsa2
and tsa1
tsa2
mutant yeasts. We also compared the function and
regulation of TSA1 and TSA2. The
tsa2
and tsa1
tsa2
cells were
indistinguishable from wild type under aerobic conditions. However, the
tsa1
tsa2
mutant yeast grew more slowly in
the presence of ROS and RNS. The antioxidant properties of Tsa1p and
Tsa2p were comparable. The basal expression level of TSA1
was significantly higher, but the transcription of TSA2 was
more potently activated in response to ROS or RNS and to the loss of
Tsa1p protein. We also provide the first evidence for the peroxynitrite
reductase activity of Tsa2p. Our findings suggest that Tsa2p cooperated
with Tsa1p to protect the yeast cells from oxidative and nitrosative stress.
 |
EXPERIMENTAL PROCEDURES |
Strains and Media--
The S. cerevisiae strain
BY4741 and its isogenic strains (Table I)
(29) were used in this study. Yeasts were grown in YPD (2% yeast
extract, 1% peptone, and 2% dextrose in H2O), YPG (2% yeast extract, 1% peptone, and 2% galactose in H2O), or
synthetic dextrose (SD) medium lacking leucine (SD
Leu), histidine
(SD
His), or uracil (SD
Ura). Cell transformation was performed using
the lithium acetate procedure (30). Culture was routinely grown at
30 °C. Peroxynitrite and dihydrorhodamine 123 were purchased from
Calbiochem. All other chemicals were from Sigma.
Construction of tsa1
and tsa2
Mutants--
DNA fragments
containing TSA1 or TSA2 open reading frame
were PCR-amplified from S. cerevisiae genomic DNA (Novagen).
The oligonucleotide primers are
5'-CGGAATTCGGTTGGCAAAGTCGGCTG (forward) and
5'-CCGCTCGAGAC GGTAGTGTATCCTT (reverse) for TSA1
(expected product size: 869 bp) and
5'-CGGAATTCGGGCGAGGCTCTCCTTTCT (forward) and
5'-CCGCTCGAGCTTATCATATAT (reverse) for TSA2
(product size: 906 bp), respectively. These primers introduce
EcoRI (forward) and XhoI (reverse) sites
(underlined). The resulting PCR fragments were gel-purified, digested
with EcoRI and XhoI, and cloned into plasmid
pBluescript II SK (Stratagene). The +52 to +447 nucleotides from the
TSA1 open reading frame were excised with SalI
and HincII and replaced with the HIS3 gene from
pDG201 (a gift from L. Derr). The +54 to +452 sequences from the
TSA2 open reading frame were removed with HincII
and HindIII and substituted with the LEU2 gene
from plasmid pGAD424 (CLONTECH). The
tsa1
disruption strains were obtained by allele
replacement using a one-step displacement method (30). The DNA
fragment, which contains the HIS3 selectable marker flanked
by the TSA1 sequence, was transformed into different strains. The tsa2
disruption strains were obtained by the
same approach, except that the DNA fragment containing the
LEU2 selectable marker flanked by the TSA2
sequence was used. The tsa1::HIS3 and tsa2::LEU2 genotypes were verified by PCR and
Southern analysis.
Construction of TSA1 and TSA2 Expression Plasmids--
To
construct inducible expression vectors for TSA1 and
TSA2, DNA fragments harboring TSA1 and
TSA2 gene were cloned into the HindIII and
XhoI sites of yeast expression vector pYEUra3
(CLONTECH). To construct pTSA1 and pTSA2 plasmids,
which express TSA1 and TSA2 under the control of
their own promoters, DNA fragments containing, respectively, the
TSA1 and TSA2 genes with ~1-kb promoter
sequences were cloned into yeast centromere plasmid pRS413
(Stratagene). These fragments were amplified from yeast genomic DNA
using primers 5'-CGGAATTCATGAATCCAATTCATT (forward)
and 5'-CCGCTCGAGACGGTAGTGTATCCTT (reverse) for
TSA1 and primers 5'-CAGAATTCATTGAATGGGCGCA
(forward) and 5'-CCGCTCGAGCTTATGATATAT (reverse) for
TSA2. The primers introduce EcoRI (forward) and
XhoI (reverse) sites (underlined). To achieve TSA1 promoter-driven expression of the TSA2 gene
and TSA2 promoter-driven expression of the TSA1
gene, the fragments containing TSA1 and TSA2
promoters were swapped between the two constructs pTSA1 and pTSA2 to
give plasmids pTSA1-2 and pTSA2-1.
Southern Blot Analyses--
Chromosomal DNA was isolated from
yeast cells as previously described (31). Southern blot analyses were
performed with 10 µg of chromosomal DNA and 32P-labeled probes.
Northern Blot Analyses and RT-PCR--
Total RNA was isolated
from yeast cells as described previously (31). Northern blotting was
performed with total RNA (10 µg) and 32P-labeled probes.
For RT-PCR, cDNA was synthesized with the Advantage® RT-for-PCR
kit (CLONTECH). The ORC5-specific
primers are 5'-TGTGACCACTCCGGAAG and 5'-GGAATGTT GGATGTGAA (expected
size of product: 264 bp). The TSA1-specific primers are
5'-CTTGGACAAATACAAG and 5'-CAAAGAGTGGTTGGTG (expected size of product:
247 bp). The TSA2-specific primers are 5'-ACTGGAAAAGTATAAA
and 5'-ATAAGGAATGATTCTTA (expected size of product: 247 bp). The
amounts of the templates were adjusted, and the conditions were
optimized to ensure that the amplification was in the linear range.
Construction of TSA1-lacZ and TSA2-lacZ Fusions--
The
TSA1-lacZ plasmid contains the
1000 to +50 sequences of
TSA1 fused to bacterial lacZ gene. Likewise, the
TSA2-lacZ fusion plasmid carries the
1000 to +50 sequences
of TSA2. The TSA1 and TSA2 fragments
containing the promoter and the first few codons of the open reading
frame were amplified from S. cerevisiae genomic DNA
(Novagen) using Pfx DNA polymerase (Invitrogen). The
oligonucleotide primers are
5'-CCGAGCTCTCGTCAAAGACACCGTC (forward) and
5'-CGGAATTCATCAATTCCAATCATT (reverse) for TSA1
and 5'- ACGCGTCGACATTCATTGAATGGGCGCAAT (forward) and
5'-CGGAATTCACTACGGCGGTTTTC (reverse) for
TSA2, respectively. The restriction sites for subcloning are
underlined. The fragments were cloned first into pBluescript II SK and
then inserted into the lacZ plasmid pEB39 (a gift from
E. A. Elion). For insertion of the lacZ gene into the
chromosomal TSA1 and TSA2 loci, the TSA1-lacZ and TSA2-lacZ plasmids were digested
with HindIII and ClaI. The DNA fragments
harboring the TSA1 and TSA2 promoters were
subcloned into pLacZi (CLONTECH). The resulting
plasmids were digested by MunI and BglII and
integrated into the yeast genomic DNA by homologous recombination. In
the TSA1-lacZ mutant yeast, the lacZ gene was
driven by the authentic TSA1 promoter, and the
TSA1 gene was under the control of another copy of the previously cloned TSA1 promoter (~1 kb). Likewise, in the
TSA2-lacZ yeast, the lacZ gene was driven by the
authentic TSA2 promoter, and the TSA2 gene was
under the control of another copy of the previously cloned
TSA2 promoter (~1 kb). The sequences of all PCR products
were confirmed by DNA sequencing, and no mutation had been introduced.
ROS Detection--
Intracellular redox levels were measured by
fluorescence microscopy or by fluorimetry using the fluorescent dye
2',7'-dichlorofluorescein diacetate. Cells were grown in YPD medium
until A600 reached 0.5. Hydrogen peroxide
was added to a final concentration of 1 mM. After an
additional incubation for 15 min, cells were collected by
centrifugation from 2 ml of culture and then washed three times with
phosphate-buffered saline (PBS). Cells were resuspended in PBS with 10 µM 2', 7'-dichlorofluorescein diacetate (Molecular Probes, Inc., Eugene, OR) and incubated at 28 °C for 1 h. The dye can react specifically with hydrogen peroxide to give a highly fluorescent 2',7'-dichlorofluorescein (DCF). Cells were collected, washed three times with PBS, mounted onto slides, and examined under a
confocal fluorescence microscope (Zeiss). An argon ion laser with an
emission line at 488 nm was used to excite DCF. Alternatively, the
cells were disrupted by glass beads, and the supernatant was collected
by centrifugation. The crude extract containing 500 µg of protein was
suspended in PBS, and the fluorescence was measured on a F-4500
spectrofluorimeter (Hitachi). The excitation and emission wavelengths
were 488 and 520 nm, respectively.
Spot Assays for Sensitivity to Oxidants--
Cells were grown in
YPD medium until A600 reached 0.5 and exposed to
oxidants for 0.5 h. Cells were then diluted and plated for colony survival.
-Galactosidase Assay--
-Galactosidase levels were
measured with treated or untreated midlog phase cells as previously
described (32, 33).
o-Nitrophenyl-
-D-galactopyranoside was used
as substrate. Activities were given in A420
units/min/mg of protein.
Flow Cytometric Analysis of DNA Content--
After two washes
with water, cells were fixed with 70% ethanol for 12 h at 4 °C
and then treated with RNase A (1 mg/ml) in PBS for 30 min at 37 °C.
Then proteinase K (10 mg/ml) was added, and the cells were further
incubated for 1 h at 55 °C. Cells were stained with propidium
iodide (50 µg/ml) in 10 mM Tris-HCl (pH 8.0), 10 mM NaCl. Stained cells were subsequently diluted in PBS, and for each sample the DNA content in 10,000 cells was determined with
a FACScan flow cytometer. Flow cytometric analysis was performed with
EXPO program (EPICS).
Expression and Purification of Histidine-tagged
Tsa2p--
A DNA fragment containing TSA2 gene was prepared
by PCR as described above and ligated into expression vector pET-28a
(Novagen). Histidine-tagged Tsa2p was expressed in E. coli
BL21 (DE3) and purified using procedures recommended by Novagen. The
purified His-Tsa2p was reduced by 5 mM DTT. The reduced
His-TSA2p was then chromatographed through a FastFlow desalting column
(Amersham Biosciences, Inc.) to remove DTT.
Peroxynitrite Reductase Assay--
The peroxynitrite-mediated
oxidation of dihydrorhodamine 123 to rhodamine was followed as
previously described (10). The final concentrations of peroxynitrite
and dihydrorhodamine 123 were 10 and 100 µM,
respectively, in potassium phosphate buffer (pH 7.0) with 100 µM diethylenetriaminepentaacetic acid. The rhodamine formation was quantitated by measurement of absorbance at a wavelength of 500 nm. Oxidized His-Tsa2p was prepared by the addition of 5 mM H2O2.
 |
RESULTS |
Molecular Evolution of Yeast Tsa1p and Tsa2p--
The yeast
S. cerevisiae is a useful model for studies of eukaryotic
antioxidant enzymes and redox signaling (1). Budding yeast Tsa1p is the
first identified peroxiredoxin (5, 34) and is one of the
best-studied members in this family (5, 7, 16, 34-36). Among the five
peroxiredoxins in yeast, Tsa2p is unique in sharing striking homology
with Tsa1p. Notably, 86% of the amino acid residues in Tsa1p and Tsa2p
are identical, and 96% are similar. The separation of TSA2
with TSA1 probably occurred after the speciation of budding
yeast, as the result of a gene duplication event. The high degree of
sequence homology suggests a conservation of function. Studies of yeast
Tsa1p and Tsa2p may derive novel insights into the biology of closely
related peroxiredoxins in other species.
Growth Phenotypes of the
tsa2 Strains--
The five mutants
deleted for individual peroxiredoxins have been shown to be viable (16,
35). This raises two not mutually exclusive possibilities that may
explain the phenotype. First, there could be functional overlap between
different peroxiredoxins. Second, all peroxiredoxins might be
dispensable for viability because of functional overlap between
peroxiredoxins and other antioxidant enzymes. One way to explore these
possibilities is through the construction of multiple
peroxiredoxin-null mutants.
We also noted that the TSA2-null strain exhibited a unique
phenotype characterized by severe growth retardation with the
accumulation of G1 cells (16). In addition, unlike other
peroxiredoxin-null mutants, the yeast strain deleted for
TSA2 was insensitive to oxidant challenge (16). A closer
examination of the tsa2
phenotype is required to further
elucidate the underlying mechanisms.
To address the above issues and to characterize the cellular functions
of yeast Tsa1p and Tsa2p, we constructed tsa2
and tsa1
tsa2
strains by replacing an internal
fragment within the coding region of TSA2 with the
LEU2 marker. PCR (Fig.
1A) and Southern blotting
(Fig. 1B) were performed to confirm the insertion of
LEU2 into the TSA2 gene. In addition, no
TSA2 mRNA was detected in tsa2
or
tsa1
tsa2
cells by Northern blotting (Fig.
1C). All three experiments consistently demonstrated the
disruption of the TSA2 gene in the tsa2
and
tsa1
tsa2
strains.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 1.
Disruption of TSA2 in
tsa2 and tsa1
tsa2 strains.
A, PCR analysis. Targeted and isogenic wild-type
TSA2 fragments in yeast were detected by PCR with specific
primers. PCR products of 0.9 and 2.3 kb in size correspond to
TSA2 and tsa2::LEU2, respectively. DNAs
amplified from the indicated strains (lanes 3-6)
were compared with the positive (+ve control;
lane 7) and negative ( ve
control; lane 2) control DNAs
amplified from plasmids. B, Southern blot analysis. The 2.5- and 4.0-kb fragments correspond to TSA2 and
tsa2::LEU2, respectively. C, Northern
blot analysis. The 0.9-kb mRNA is specific for TSA2. As a control
for equal loading, the staining with ethidium bromide is shown in the
lower panel.
|
|
The tsa1
, tsa2
, and tsa1
tsa2
strains were all viable, indicating that neither
TSA1 nor TSA2 is essential for normal aerobic growth. In addition, both
the tsa2
and the tsa1
tsa2
strains showed wild-type growth rate in rich (YPD; Fig.
2A) or minimal (SD; data not
shown) medium. The tsa2
and tsa1
tsa2
mutants were indistinguishable from the isogenic
wild-type BY4741 strain either in growth (Fig. 2A) or in
cell morphology (data not shown). Next, we performed flow cytometric
analysis to assess the DNA content and to compare the cell cycle
profiles of the wild-type and mutant yeasts (Fig. 2B).
Again, the tsa2
(panel 3) and
tsa1
tsa2
(panel 4)
strains did not show any difference from the BY4741 (panel
1) or tsa1
(panel 2)
cells. Notably, the distribution profiles of G1/S and
G2/M cells in the four strains were very similar. In sharp
contrast to a previous report (16), the G1 peak in either
the tsa2
yeast or the tsa1
tsa2
double mutant is not higher than in the BY4741 or
tsa1
strain (i.e. we did not observe the
accumulation of G1 cells in the tsa2
strains).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
The tsa2 and
tsa1 tsa2
mutants grew normally in aerobic culture. A, the
growth rates of tsa1 , tsa2 ,
tsa1 tsa2 , and isogenic wild-type cells.
Wild-type S. cerevisiae BY4741 strain ( ),
tsa1 ( ), tsa2 ( ), and
tsa1 tsa2 ( ) cells were aerobically
cultured in YPD medium at 30 °C, and their optical densities at 600 nm (OD600) were measured every 3 h.
B, flow cytometric analysis of DNA content. Samples were
taken from midlog phased cells (A600 at 1), and
10,000 cells from each sample were analyzed. Three independent
experiments were carried out with similar results.
|
|
Sensitivity of tsa2
Strains to Oxidants--
The exponentially
growing TSA2-null yeast cells have been shown to be
insensitive to oxidants (16). Because the behaviors of our
tsa2
strains were different from the reported slow growth phenotype, we sought to reexamine the sensitivity of our
tsa2
strains to oxidants and the antioxidant response in
these strains.
First we challenged the four yeast strains (wild-type BY4741,
tsa1
, tsa2
, and tsa1
tsa2
) with H2O2 and
t-butylhydroperoxide (t-BHP). The sensitivity was
assessed in the spot assay (Fig. 3A). Consistent with our
findings from growth rate studies (Fig. 2A) and flow
cytometric analysis (Fig. 2B), the four strains grew normally in the absence of oxidant insult (Fig. 3A,
lanes 1-3). However, the tsa2
cells were more sensitive to peroxides than the wild type BY4741 but
less sensitive than the tsa1
cells (Fig. 3A,
lanes 6 and 9). This implicates that
Tsa2p plays a significant, albeit secondary, role in the cellular
response to oxidants. Among the four isogenic strains, the double
mutant tsa1
tsa2
is most sensitive to
oxidant challenge, suggesting that Tsa1p and Tsa2p cooperate in the
antioxidant defense.

View larger version (116K):
[in this window]
[in a new window]
|
Fig. 3.
Sensitivity of tsa2
mutants to oxidative stress. A, spot assay. The
indicated cells were grown in YPD medium until
A600 reached 0.5 and then were treated with 1 mM H2O2 or 1 mM
t-BHP for 2 h. Serial dilutions were spotted on YPD
plates. The cells were incubated at 30 °C for 2 days. B,
DCF oxidation assay. The indicated cells were grown in YPD medium until
A600 reached 0.5, were treated first with 1 mM H2O2 and then with 10 µM 2',7'-dichlorofluorescein diacetate, and were examined
by fluorescence microscopy. Relative intensity (rel. int.)
was calculated from 100 cells from each group. The light fields
(panels 1, 3, 5, and
7) and the DCF fluorescence (panels 2,
4, 6, and 8) for the same fields of
cells (panels 1 and 2, 3 and 4, 5 and 6, and 7 and
8) were shown at ×100 magnification.
|
|
The antioxidant properties of peroxiredoxins to protect cells from
oxidant insult are ascribed to their ability to scavenge hydrogen
peroxide (7). To follow more closely the removal of H2O2, we measured the levels of intracellular
H2O2 in the four strains by confocal
fluorescence microscopy using the fluorescent probe
2',7'-dichlorofluorescein diacetate (Fig. 3B). This dye has
been widely used for ROS detection (17), and it reacts specifically with H2O2 to produce a highly fluorescent DCF.
We observed that the DCF fluorescence in all three mutants (Fig.
3B, panels 4, 6, and
8) significantly increased compared with that in the
parental wild-type strain BY4741 (panel 2). The
relative intensity of the fluorescence in the four strains was in the
following order: tsa1
tsa2
> tsa1
> tsa2
> BY4741 (Fig.
3B). This order is generally consistent with the sequence of
sensitivity to oxidants (Fig. 3A).
Sensitivity of tsa1
and tsa2
Strains to RNS--
Bacterial
peroxiredoxin AhpC has peroxynitrite reductase activity (10) and
therefore confers resistance to RNS (11). Yeast Tsa1p and Tsa2p are in
the same subfamily as AhpC. However, it remains to be seen whether
Tsa1p, Tsa2p, and eukaryotic peroxiredoxins can protect cells from RNS.
To address this question, we tested the sensitivity of TSA1-
and/or TSA2-null strains to peroxynitrite and sodium
nitroprusside (SNP).
As a product of nitric oxide and superoxide, peroxynitrite
(ONOO
) is a potent oxidizing and nitrating species with
mutagenic, proapoptotic, and cytotoxic activities. Peroxynitrite has
been implicated in the pathogenesis of various diseases (37). SNP is a
nitric oxide donor frequently used in biomedical research and in
clinical practice (37). When the four yeast strains were exposed to 1 mM peroxynitrite, the tsa1
,
tsa2
, and tsa1
tsa2
strains
were significantly more susceptible than the wild-type BY4741 (Fig.
4A). Similarly, the
tsa1
yeast was more sensitive to 2 mM SNP
than BY4741. While no difference in the sensitivity of the
tsa2
and the parental BY4741 strains to SNP was noted, the tsa1
tsa2
double mutant displayed an
increased sensitivity compared with the BY4741 and tsa1
strains (Fig. 4B). Collectively, these results support a
model in which Tsa1p cooperates with Tsa2p in the protection against
RNS.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
Sensitivity of tsa2
mutants to peroxynitrite and SNP. A, sensitivity
to peroxynitrite. Cells were grown to saturation, diluted to an
A600 of 0.2, and then treated with 1 mM peroxynitrite. B, sensitivity to SNP. Cells
were grown to saturation, diluted to an A600 of
0.2, and then treated with 2 mM SNP. C,
sensitivity of TSA1-transformed mutants to SNP. The
tsa1 , tsa2 , and tsa1
tsa2 strains (curves 2-4) were
transformed with a TSA1 expression plasmid driven by the
TSA1 promoter. The transformants were compared with the
mock-transformed BY4741 strain (curve 1).
D, sensitivity of TSA2-transformed mutants to
SNP. The tsa1 , tsa2 , and tsa1
tsa2 strains (curves 2-4) were
transformed with a TSA2 expression plasmid driven by the
TSA2 promoter. The transformants were compared with the
mock-transformed BY4741 strain (curve 1).
E, expression of Tsa1p or Tsa2p rescues the sensitivity to
SNP. The tsa1 tsa2 strain was transformed
individually with either pTSA1-2 (curve 5) or
pTSA2-1 (curve 6). The expression of Tsa2p from
pTSA1-2 was driven by a TSA1 promoter ( 1000 to +52
nucleotides). In pTSA2-1, a TSA2 promoter ( 1000 to +52
nucleotides) was used to control the expression of Tsa1p.
|
|
To verify the specificity of action, we performed complementation
assays with TSA1 or TSA2. A centromere expression
plasmid for TSA1 was transformed into the
tsa1
, tsa2
, and tsa1
tsa2
strains (Fig. 4C). The growth rates of
the four strains were indistinguishable, indicating that the expression
of TSA1 driven by the TSA1 promoter fully
complemented the deficiency of TSA1 and/or TSA2.
In contrast, the expression of TSA2 driven by the
TSA2 promoter complemented the defects in TSA1
and/or TSA2 partially (Fig. 4D). Conceivably, the
incompleteness of the effect may arise from the inefficient expression
and/or the lower antioxidant activity of the protein. To shed
additional light on this, we swapped the TSA1 and
TSA2 promoters and constructed plasmids pTSA1-2 and pTSA2-1.
The expression of Tsa2p from plasmid pTSA1-2 was regulated by the
TSA1 promoter. Vice versa, the TSA2 promoter was
used to drive the expression of Tsa1p from pTSA2-1. Interestingly, the
tsa1
tsa2
strain harboring the pTSA1-2
plasmid (Fig. 4E, curve 5) was as
resistant to SNP as the BY4741 yeast (curve 1),
indicating that the expression of Tsa2p alone sufficiently protected
cells from SNP challenge. Likewise, the pTSA2-1 plasmid conferred
substantial but not full protection against SNP (Fig. 4E,
curve 6). One interpretation for the partial
effect is that the TSA2 promoter is less potent than the
TSA1 promoter. This hypothesis is supported further by the
facts that both TSA1 (Fig. 4C) and
TSA1-2 (Fig. 4E, curve 5)
are fully competent in the defense against SNP.
Peroxynitrite Reductase Activity of Tsa2p--
In light of the
ability of Tsa1p and Tsa2p to protect cells against RNS (Fig. 4), we
asked whether Tsa2p might catalytically detoxify peroxynitrite. One
efficient and selective method to detect peroxynitrite is through the
oxidation of dihydrorhodamine 123 to rhodamine 123 (10). We expressed
His-tagged Tsa2p protein in E. coli and purified it to
>90% homogeneity as assessed on nonreducing and reducing PAGE gel
(Fig. 5A). We incubated the purified His-Tsa2p with 5 mM DTT and then removed DTT by
gel filtration. When this preparation of reduced His-Tsa2p was added to
the reaction containing peroxynitrite and dihydrorhodamine 123, we
observed a pronounced inhibition of rhodamine 123 formation (Fig.
5B, curve 3). Notably, neither bovine
serum albumin treated with DTT in the same way as His-Tsa2p (Fig.
5B, curve 1) nor oxidized His-Tsa2p preincubated with 5 mM H2O2
(curve 2) had a significant effect on
peroxynitrite-mediated oxidation of dihydrorhodamine 123. Moreover, we
demonstrated that the oxidation of His-Tsa2p by peroxynitrite (Fig.
5C, lanes 1 and 2) can be
reversed by the addition of
-mercaptoethanol (lane
3). Because the appearance of dimeric Tsa2p probably
reflects the formation of an interchain disulfide bond, peroxynitrite
may oxidize Tsa2p reversibly on cysteine residues. Thus, Tsa2p acts as
a peroxynitrite reductase in vitro.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Peroxynitrite reductase activity of Tsa2p
in vitro. A, PAGE analysis of reduced
and oxidized Tsa2p. His-Tsa2p (5 µg) purified from E. coli
was separated by 12% nonreducing (lane 1) or
reducing (lane 2; with 5 mM DTT in
the protein sample) PAGE, and the gel was stained with Coomassie Blue
R-250. Dimeric (*) and monomeric (#) forms of Tsa2p were indicated.
M, protein molecular mass marker. B, protection
of peroxynitrite-mediated oxidation of dihydrorhodamine 123 by Tsa2p.
Reactions contained 100 µM diethylenetriaminepentaacetic
acid and 100 µM dihydrorhodamine 123 in phosphate buffer
(pH 7.0) and the indicated concentrations of bovine serum
albumin (treated with and then separated from 5 mM DTT;
curve 1, ), oxidized His-Tsa2p (treated with 5 mM H2O2; curve
2, ), or reduced His-Tsa2p (treated with and then
separated from 5 mM DTT; curve 3,
). Peroxynitrite (10 µM) was added, and rhodamine
formation was measured by absorbance at the 500-nm wavelength.
C, reversible oxidation of Tsa2p. Reduced His-tagged Tsa2p
(treated with and then separated from 5 mM DTT;
lane 1) was first oxidized by 10 µM
peroxynitrite (lane 2) and subsequently reduced
again by 5% -mercaptoethanol (lane 3). The
protein samples were analyzed as in A.
|
|
Comparison of the H2O2-scavenging
Activities of Tsa1p and Tsa2p in Vivo--
One previous study suggests
that the specific thioredoxin-dependent peroxidase activity
of Tsa1p in vitro is 6-fold higher than that of Tsa2p (16).
Above we showed that the expression of either Tsa1p or Tsa2p in yeasts
sufficiently protected cells from ROS and RNS. To further characterize
the antioxidant activities of Tsa1p and Tsa2p, we compared their
H2O2-removing activities in
vivo.
For this experiment, we constructed inducible expression plasmids for
Tsa1p and Tsa2p. A GAL1 promoter was used to control the
expression of Tsa1p and Tsa2p in plasmids pTSA1 and pTSA2, respectively. The tsa1
tsa2
double mutant
was transformed individually with the empty vector, pTSA1, and pTSA2.
The expression of Tsa1p and Tsa2p was induced by transferring the
yeasts to a medium containing galactose. The cells were treated with
H2O2, and the fluorescent dye
2',7'-dichlorofluorescein diacetate was added to chase the removal of
H2O2. The DCF fluorescence reflects the
relative levels of intracellular ROS. From the representative fields of
cells under the fluorescence microscope (Fig.
6A) and from the quantitation based on a fluorimeter (Fig. 6B), the expression of either
Tsa1p or Tsa2p led to a substantial reduction of DCF fluorescence,
which reflects the removal of intracellular
H2O2. Tsa1p appeared to be a more potent
peroxidase in this assay. For all, the
H2O2-scavenging activities of the two
peroxiredoxins were comparable. These data implicate that both Tsa1p
and Tsa2p are active peroxidases in vivo.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 6.
Peroxidase activity of Tsa1p and Tsa2p
in vivo. A, DCF oxidation. The
tsa1 tsa2 yeasts were transformed
individually with empty vector (pYEUra3 from
CLONTECH), with pTSA1, or with pTSA2. The
expression of Tsa1p and Tsa2p from pTSA1 and pTSA2, respectively, was
driven by an inducible GAL1 promoter. The yeasts were
initially grown in SD Ura with 2% glucose. To induce the expression
of Tsa1p and Tsa2p, cells were transferred to YPG medium containing 2%
galactose, cultured for an additional 2 h, treated first with 1 mM H2O2 and then with 10 µM 2', 7'-dichlorofluorescein diacetate, and examined
under a confocal fluorescence microscope. The DCF fluorescence
(panels 1-3) and the light fields
(panels 4-6) for the same fields of cells
(panels 1 and 4, 2 and
5, and 3 and 6) were shown at ×100
magnification. B, quantitation of DCF fluorescence. Cells
were disrupted by glass beads, and the fluorescence was measured on an
F-4500 spectrofluorimeter. The fluorescence intensity of the
tsa1 tsa2 cells transformed with an empty
vector was taken as 100%. Results represent the average of three
independent experiments, and error bars indicate
S.E. RT-PCR was performed to verify the expression of TSA1
and TSA2 genes (inset). The housekeeping gene
ORC5 was used as a control.
|
|
Comparison of the Basal Transcriptional Activities of TSA1 and
TSA2--
The above data suggested that the TSA1 promoter
might be stronger than the TSA2 promoter (Fig. 5,
C-E). To formally compare their basal activities, we
performed lacZ reporter assays. Reporter plasmids
(2µ-based) driven by the TSA1 and TSA2
promoters (TSA1-lacZ and TSA2-lacZ) were
transformed into the BY4741 strain. The
-galactosidase activity was
assayed and compared. In this assay, the TSA1 promoter is
about 3 times stronger than the TSA2 promoter (Fig.
7). Results from the semiquantitative
RT-PCR analysis of the TSA1 and TSA2 transcripts
in untransformed BY4741 cells lent further support to the notion that
the basal transcriptional level of TSA1 is significantly
higher (Fig. 7, inset).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 7.
The basal expression levels of
TSA1 and TSA2 genes. The BY4741
yeast was transformed individually with pTSA1-lacZ and pTSA2-lacZ.
Cells were cultured in YPD medium to log phase, and -galactosidase
activity was measured. Results represent three independent experiments,
and error bars indicate S.E. Semiquantitative
RT-PCR was performed to compare the mRNA expression levels in the
untransformed BY4741 strain (inset). The housekeeping gene
ORC5 was used as a control. The expected sizes of the
ORC5, TSA1, and TSA2 amplification
products are similar (264, 247, and 247 bp).
|
|
Differential Regulation of TSA1 and TSA2 by ROS and RNS--
While
the basal expression levels of TSA1 and TSA2 were
different (Fig. 7), both genes have been shown to be induced by
H2O2 and diamide (16). To investigate the
transcriptional regulation of the chromosomal TSA1 and
TSA2 loci, we inserted the lacZ reporter immediately downstream of the chromosomal TSA1 and
TSA2 promoters. The expression of the Tsa1p/Tsa2p was
rescued by simultaneously introducing an extra copy of the
TSA1/TSA2 promoter immediately upstream of the
coding region. In this setting, the integrated single copy
lacZ reporter may better reflect the transcriptional activities of the chromosomal TSA1 and TSA2 genes.
We compared the relative
-galactosidase activities of the
TSA1-lacZ and TSA2-lacZ strains in the presence
of H2O2, t-BHP, diamide,
peroxynitrite, and SNP (Fig. 8).
Interestingly, the activities of the TSA1 promoter did not
change substantially in response to ROS or RNS (Fig. 8A). In
most cases, the increase in transcriptional level was less than 50%.
The stimulation by t-BHP was less than 2-fold. By sharp
contrast, the induction of TSA2 promoter by
H2O2, t-BHP, diamide, and
peroxynitrite was much more dramatic, ranging from 5- to 11-fold (Fig.
8B). Similar results were obtained from strains transformed
with 2µ-based TSA1-lacZ and TSA2-lacZ plasmids (data not shown). These data provide the evidence for differential regulation of TSA1 and TSA2 genes in response to
ROS and RNS.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
Induction of TSA1 and
TSA2 expression in response to oxidative or
nitrosative stress. A, induction of the
TSA1-lacZ mutant yeast. B, induction of the
TSA2-lacZ mutant yeast. A single copy of the lacZ
gene integrated into the yeast genome was driven by the chromosomal
TSA1 or TSA2 promoter. Cells were cultured in YPD medium to log phase
and treated with 0.5 mM H2O2, 1 mM t-BHP, 1 mM diamide, 0.5 mM peroxynitrite, or 2 mM SNP.
-galactosidase activity of the untreated control cells
(column 1) was taken as 100%. Results are
representative of three independent experiments, and error
bars indicate S.E.
|
|
Compensational Activation of TSA2 in tsa1
Strain--
To better
understand the functional overlap between Tsa1p and Tsa2p, we asked
whether TSA1 is activated in the tsa2
strain, and vice versa. We observed that the activity of TSA1-lacZ
was only slightly increased in the tsa2
strain either in
the absence or in the presence of H2O2 (Fig.
9A). The TSA1-lacZ
activity was substantially reduced in the yap1
tsa2
strain, implying that the basal activation of
TSA1 is mediated through the redox-regulated transcription
factor Yap1p. In contrast, the TSA2-lacZ activity significantly increased in the tsa1
strain (Fig.
9B). We also noted that the TSA2-lacZ activity
was lost almost completely in the yap1
tsa1
strain. One interpretation is that the Yap1p is responsible for both
the basal and the induced activation of TSA2.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 9.
Compensational activation of Tsa2p in
tsa1 cells depends on Yap1p.
A, activity of TSA1-lacZ reporter plasmid in
tsa2 cells. B, activity of
TSA2-lacZ reporter plasmid in tsa1 cells.
Results represent three independent experiments, and error
bars indicate S.E. C, RT-PCR. RT-PCR was
performed to verify the transcriptional levels of TSA1 and
TSA2 genes. The housekeeping gene ORC5 was used
as a control.
|
|
To verify that the lacZ reporter activity reflects the
authentic TSA1 and TSA2 genes, we performed
semiquantitative RT-PCR to compare the relative amounts of
TSA1 and TSA2 mRNA in BY4741, tsa1
, and tsa2
strains (Fig.
9C). Consistent with the results from the reporter assay,
the TSA2 mRNA was more abundantly expressed in the
tsa1
strain (compare lane 2 with
lane 1 and lane 5 with lane 4). This compensational activation suggests
that TSA2 may play a more important role when
TSA1 is compromised.
 |
DISCUSSION |
In this study, we used a genetic approach (Fig. 1) to characterize
the function and regulation of yeast peroxiredoxins Tsa1p and Tsa2p.
The tsa2
and tsa1
tsa2
yeast
strains were viable and indistinguishable from the parental wild type
under aerobic conditions (Fig. 2). However, the disruption of
TSA1 and/or TSA2 conferred hypersensitivity to
RNS (Fig. 4) in addition to ROS (Fig. 3). In line with this, Tsa2p acts
as a peroxynitrite reductase to protect against peroxynitrite-mediated
oxidation in vitro (Fig. 5). The in vivo
H2O2-scavenging activities of Tsa1p and Tsa2p were comparable (Fig. 6), but the basal expression level of
TSA1 was significantly higher (Fig. 7). While the
transcription of TSA2 was potently activated in response to
ROS/RNS (Fig. 8B) and as a result of TSA1
disruption (Fig. 9), the expression of TSA1 was less
responsive to stimuli (Fig. 8A). Our findings support the
model in which Tsa2p cooperated with the primary cytoplasmic peroxiredoxin Tsa1p in the cellular defense against oxidative and
nitrosative stress.
Tsa2p Is a Functional Antioxidant Enzyme in Yeast--
Tsa2p is
closely related to the well described Tsa1p. The separation of these
two peroxiredoxins probably arose from a gene duplication event after
the speciation of budding yeast. A previous study (16) has described
two unique characteristics of a TSA2-null mutant: the
insensitivity to oxidants and the induction of growth retardation
presented as G1 arrest. In addition, Tsa2p has a low thioredoxin peroxidase activity in vitro (16). In the
present work, we did not observe the slow growth phenotype in
tsa2
strains (Fig. 2). We wondered how the particular
genetic background of the tsa2
strain used in Ref. 16 or
changes other than the loss of TSA2 might explain the
different observations. We also presented several lines of evidence to
support the notion that Tsa2p is a functional antioxidant enzyme
in vivo. First, the tsa2
and tsa1
tsa2
strains are more sensitive to ROS
and RNS than the parental BY4741 and tsa1
strains,
respectively (Figs. 3 and 4). Second, the expression of TSA2
driven by different promoters can partially or fully rescue the
hypersensitivity to SNP caused by disruption of TSA1 and/or
TSA2 (Fig. 4, D and E). Third, Tsa2p acts as a peroxynitrite reductase in vitro (Fig. 5). Fourth,
the overexpression of TSA2 under the control of the
inducible GAL1 promoter can effectively scavenge
H2O2 in the tsa1
tsa2
cells (Fig. 6). Tsa2p appears to be a more active
peroxidase in vivo (Fig. 6) than in vitro (16).
It remains unanswered whether electron donors other than thioredoxin
can support the peroxidase and peroxynitrite reductase activities of
Tsa2p and other peroxiredoxins. In this regard, cyclophilin A has
recently been shown as a binding partner as well as peroxidase
activator of mammalian peroxiredoxins (38). It would be of interest to
see whether yeast cyclophilins might serve similar functions to support
the antioxidant activities of peroxiredoxins. Last but not least, the
expression of TSA2 was stimulated potently by ROS and RNS
(Fig. 8). Our findings argue for an important role of Tsa2p in the
antioxidant defense.
Tsa1p and Tsa2p Protect Cells against RNS--
The disruption of
TSA1 and/or TSA2 conferred susceptibility to
peroxynitrite and SNP (Fig. 4, A and B). In
addition, the expression of either TSA1 or TSA2
sufficiently reversed this phenotype (Fig. 5, C-E). Thus,
we provide the first evidence that eukaryotic peroxiredoxins conferred
resistance to RNS. This appears to be a biological function conserved
in both prokaryotic and eukaryotic peroxiredoxins (11). In support of
this, we demonstrate for the first time the peroxynitrite reductase
activity of Tsa2p in vitro (Fig. 5). Thus, bacterial peroxiredoxin AphC (10), yeast Tsa2p (this study), and bovine peroxiredoxin VI (also known as 1-Cys peroxiredoxin; Ref. 39) can act
as peroxynitrite reductase to directly protect cells against peroxynitrite-mediated oxidations. Since these three peroxiredoxins are
from different species and different subfamilies, it is tempting to
assume that most if not all peroxiredoxins might conserve the same
property in the cellular defense against RNS.
Differential Expression and Cooperation of Tsa1p and
Tsa2p--
TSA1 and TSA2 are differentially
regulated in yeasts. On one hand, the basal transcription level of
TSA1 is significantly higher (Fig. 7). This implicates that
Tsa1p serves as a primary or principal housekeeping antioxidant enzyme
in the cellular defense against ROS and RNS. In this regard, Tsa2p is
secondary and functions as an antioxidant enzyme in reserve. This model
can explain the relative sensitivity of the tsa1
,
tsa2
, and tsa1
tsa2
strains to ROS and RNS (Figs. 3 and 4). On the other hand, the transcription of
TSA2 is induced substantially in response to ROS, RNS, and the absence of TSA1 (Figs. 8 and 9). This induction
indicates that Tsa2p plays a particularly important role in the
adaptation to oxidative and nitrosative stress. Our findings are
generally consistent with results from several genome-wide proteomic or microarray analyses (40-42). The differential expression of Tsa1p and
Tsa2p suggests that these two peroxiredoxins may fulfill their functions in different phases of the cellular response to stress.
The cooperation between Tsa1p and Tsa2p is supported by three lines of
data. First, the tsa1
tsa2
strain is more
sensitive to ROS (Fig. 3) and RNS (Fig. 4) than the tsa1
strain. These results support the additive action of Tsa1p and Tsa2p.
Second, the expression of TSA2 is activated in response to
the loss of TSA1 (Fig. 9). Third, the induced overexpression
of TSA2 alone can sufficiently complement the loss of
TSA1 (Fig. 4). Taken together, the differentially expressed
yeast peroxiredoxins Tsa1p and Tsa2p serve similar functions, and they
cooperate with each other in the cellular defense against oxidative and
nitrosative stress.
 |
ACKNOWLEDGEMENTS |
We thank M. M. K. Tsui and D. K. Benfield for technical help with yeast genetics; T. K. T. Chin for technical advice in protein purification; Y. P. Ching and
O. S. W. Wong for helpful discussions; L. Derr and E. A. Elion for reagents; and Y. P. Ching, A. C. S. Chun,
O. S. W. Wong, and S. F. Chan for critical reading of
the manuscript.
 |
FOOTNOTES |
*
This work was supported by a grant from the Hong Kong
Research Grants Council (Project HKU 7240/00M) (to D.-Y. J.) and a
research initiation grant from the Committee on Research and Conference Grants, University of Hong Kong (to D.-Y. J.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Leukemia and Lymphoma Society Scholar. To whom correspondence
should be addressed: Dept. of Biochemistry, The University of Hong
Kong, 3/F New Medical Complex, Sassoon Rd., Pokfulam, Hong Kong. Tel.:
852-28199245; Fax: 852-28551254; E-mail: dyjin@hkucc.hku.hk.
Published, JBC Papers in Press, December 10, 2001, DOI 10.1074/jbc.M106846200
 |
ABBREVIATIONS |
The abbreviations used are:
ROS, reactive oxygen
species;
RNS, reactive nitrogen species;
DCF, 2',7'-dichlorofluorescein;
PBS, phosphate-buffered saline;
SNP, sodium
nitroprusside;
t-BHP, t-butylhydroperoxide;
DTT, dithiothreitol;
RT, reverse transcription.
 |
REFERENCES |
| 1.
|
Jamieson, D. J.
(1998)
Yeast
14,
1511-1527[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Nathan, C.,
and Shiloh, M. U.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
8841-8848[Abstract/Free Full Text]
|
| 3.
|
Marshall, H. E.,
Merchant, K.,
and Stamler, J. S.
(2000)
FASEB J.
14,
1889-1900[Abstract/Free Full Text]
|
| 4.
|
Chae, H. Z.,
Robison, K.,
Poole, L. B.,
Church, G.,
Storz, G.,
and Rhee, S. G.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7017-7021[Abstract/Free Full Text]
|
| 5.
|
Chae, H. Z.,
Chung, S. J.,
and Rhee, S. G.
(1994)
J. Biol. Chem.
269,
27670-27678[Abstract/Free Full Text]
|
| 6.
|
Jin, D.-Y.,
and Jeang, K.-T.
(2000)
in
Antioxidant and Redox Regulation of Genes
(Sen, C. K.
, Siers, H.
, and Baeuerle, P. A., eds)
, pp. 381-407, Academic Press, Inc., San Diego, CA
|
| 7.
|
Netto, L. E. S.,
Chae, H. Z.,
Kang, S. W.,
Rhee, S. G.,
and Stadtman, E. R.
(1996)
J. Biol. Chem.
271,
15315-15321[Abstract/Free Full Text]
|
| 8.
|
Schröder, E.,
Littlechild, J. A.,
Lebedev, A. A.,
Errington, N.,
Vagin, A. A.,
and Isupov, M. N.
(2000)
Structure
8,
605-615[Medline]
[Order article via Infotrieve]
|
| 9.
|
Alphey, M. S.,
Bond, C. S.,
Tetaud, E.,
Fairlamb, A. H.,
and Hunter, W. N.
(2000)
J. Mol. Biol.
300,
903-916[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Bryk, R.,
Griffin, P.,
and Nathan, C.
(2000)
Nature
407,
211-215[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Chen, L.,
Xie, Q.,
and Nathan, C.
(1998)
Mol. Cell
1,
795-805[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Jeong, J. S.,
Kwon, S. J.,
Kang, S. W.,
Rhee, S. G.,
and Kim, K.
(1999)
Biochemistry
38,
776-783[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Lee, J.,
Spector, D.,
Godon, C.,
Labarre, J.,
and Toledano, M. B.
(1999)
J. Biol. Chem.
274,
4537-4544[Abstract/Free Full Text]
|
| 14.
|
Verdoucq, L.,
Vignols, F.,
Jacquot, J. P.,
Chartier, Y.,
and Meyer, Y.
(1999)
J. Biol. Chem.
274,
19714-19722[Abstract/Free Full Text]
|
| 15.
|
Pedrajas, J. R.,
Miranda-Vizuete, A.,
Javanmardy, N.,
Gustafsson, J. A.,
and Spyrou, G.
(2000)
J. Biol. Chem.
275,
16296-16301[Abstract/Free Full Text]
|
| 16.
|
Park, S. G.,
Cha, M. K.,
Jeong, W.,
and Kim, I. H.
(2000)
J. Biol. Chem.
275,
5723-5732[Abstract/Free Full Text]
|
| 17.
|
Kang, S. W.,
Chae, H. Z,
Seo, M. S.,
Kim, K.,
Baines, I. C.,
and Rhee, S. G.
(1998)
J. Biol. Chem.
273,
6297-6302[Abstract/Free Full Text]
|
| 18.
|
Jin, D.-Y.,
Chae, H. Z.,
Rhee, S. G.,
and Jeang, K.-T.
(1997)
J. Biol. Chem.
272,
30952-30961[Abstract/Free Full Text]
|
| 19.
|
Kang, S. W.,
Baines, I. C.,
and Rhee, S. G.
(1998)
J. Biol. Chem.
273,
6303-6311[Abstract/Free Full Text]
|
| 20.
|
Singh, A. K.,
and Shichi, H.
(1998)
J. Biol. Chem.
273,
26171-26178[Abstract/Free Full Text]
|
| 21.
|
Frank, S.,
Munz, B.,
and Werner, S.
(1997)
Oncogene
14,
915-921[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Haridas, V., NI, J.,
Meager, A., Su, J., Yu, G. L.,
Zhai, Y.,
Kyaw, H.,
Akama, K. T., Hu, J.,
Van, E. L.,
and Aggarwal, B. B.
(1998)
J. Immunol.
161,
1-6[Abstract/Free Full Text]
|
| 23.
|
Lyu, M. S.,
Rhee, S. G.,
Chae, H. Z.,
Adamson, M. C.,
Kang, S. W.,
Jin, D,-Y,
Jeang, K. T.,
and Kozak, C. A.
(1999)
Mamm. Genome
10,
1017-1019[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Wong, C.-M.,
Chun, A. C. S.,
Kok, K. H.,
Zhou, Y.,
Fung, P. C. W.,
Kung, H.-F.,
Jeang, K.-T.,
and Jin, D. Y.
(2000)
Antioxidants Redox Signal.
2,
507-518[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Yamashita, H.,
Avraham, S.,
Jiang, S.,
London, R.,
Van Veldhoven, P. P.,
Subramani, S.,
Rogers, R. A.,
and Avraham, H.
(1999)
J. Biol. Chem.
274,
29879-29904
|
| 26.
|
Knoops, B.,
Clippe, A.,
Bogard, C.,
Arsalane, K.,
Wattiez, R.,
Hermans, C.,
Duconseille, E.,
Falmagne, P.,
and Bernard, A.
(1999)
J. Biol. Chem.
274,
30451-30548[Abstract/Free Full Text]
|
| 27.
|
Zhou, Y.,
Kok, K. H.,
Chun, A. C.,
Wong, C. M., Wu, H. W.,
Lin, M. C.,
Fung, P. C.,
Kung, H.,
and Jin, D.-Y.
(2000)
Biochem. Biophys. Res. Commun.
268,
921-927[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Seo, M. S.,
Kang, S. W.,
Kim, K.,
Baines, I. C.,
Lee, T. H.,
and Rhee, S. G.
(2000)
J. Biol. Chem.
275,
20346-30354[Abstract/Free Full Text]
|
| 29.
|
Winzeler, E. A.,
Shoemaker, D. D.,
Astromoff, A.,
et al..
(1999)
Science
285,
901-906[Abstract/Free Full Text]
|
| 30.
|
Gietz, D., St.,
Jean, A.,
Woods, R. A.,
and Schiestl, R. H.
(1992)
Nucleic Acids Res.
20,
1425[Free Full Text]
|
| 31.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1994)
Current Protocols in Molecular Biology
, John Wiley & Sons, Inc., New York
|
| 32.
|
Miller, J. H.
(1972)
Experiments in Molecular Genetics
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 33.
|
Jin, D.-Y.,
and Jeang, K.-T.
(1997)
Nucleic Acids Res.
25,
379-387[Abstract/Free Full Tex |